Luca Castagna


Ontology type: schema:Person     


Person Info

NAME

Luca

SURNAME

Castagna

Publications in SciGraph latest 50 shown

  • 2022-09-03 Impact of second-degree related donor on the outcomes of T cell-replete haploidentical transplantation with post-transplant cyclophosphamide in BONE MARROW TRANSPLANTATION
  • 2022-06-25 Reduced intensity versus non-myeloablative conditioning regimen for haploidentical transplantation and post-transplantation cyclophosphamide in complete remission acute myeloid leukemia: a study from the ALWP of the EBMT in BONE MARROW TRANSPLANTATION
  • 2022-05-13 Impact of donor kinship on non-T-cell depleted haploidentical stem cell transplantation with post transplantation cyclophosphamide for acute leukemia: From the ALWP of the EBMT in BONE MARROW TRANSPLANTATION
  • 2022-01-25 Post-transplant cyclophosphamide in one-antigen mismatched unrelated donor transplantation versus haploidentical transplantation in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the EBMT in BONE MARROW TRANSPLANTATION
  • 2022-01-13 The association of graft-versus-leukemia effect and graft-versus host disease in haploidentical transplantation with post-transplant cyclophosphamide for AML in BONE MARROW TRANSPLANTATION
  • 2021-07-14 Cytokine release syndrome after haploidentical hematopoietic cell transplantation: an international multicenter analysis in BONE MARROW TRANSPLANTATION
  • 2021-03-22 Chemotherapy-based versus chemotherapy-free stem cell mobilization (± plerixafor) in multiple myeloma patients: an Italian cost-effectiveness analysis in BONE MARROW TRANSPLANTATION
  • 2021-03-05 Prognostic factors for neutrophil engraftment after haploidentical cell transplantation with PT-Cy in patients with acute myeloid leukemia in complete remission, on behalf of the ALWP-EBMT in BONE MARROW TRANSPLANTATION
  • 2021-03-03 Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma in LEUKEMIA
  • 2020-11-24 Haploidentical related donor compared to HLA-identical donor transplantation for chemosensitive Hodgkin lymphoma patients in BMC CANCER
  • 2020-11-15 Allogeneic stem cell transplantation in poor prognosis peripheral T-cell lymphoma: the impact of different donor type on outcome in BONE MARROW TRANSPLANTATION
  • 2020-10-12 Tandem autologous-reduced intensity allogeneic stem cell transplantation in high-risk relapsed Hodgkin lymphoma: a retrospective study of the Lymphoma Working Party—EBMT in BONE MARROW TRANSPLANTATION
  • 2020-05-06 Post-transplant cyclophosphamide after matched sibling, unrelated and haploidentical donor transplants in patients with acute myeloid leukemia: a comparative study of the ALWP EBMT in JOURNAL OF HEMATOLOGY & ONCOLOGY
  • 2019-09-18 Posttransplantation cyclophosphamide vs. antithymocyte globulin as GVHD prophylaxis for mismatched unrelated hematopoietic stem cell transplantation in BONE MARROW TRANSPLANTATION
  • 2019-03-19 Peripheral blood stem cell for haploidentical transplantation with post-transplant high dose cyclophosphamide: detailed analysis of 181 consecutive patients in BONE MARROW TRANSPLANTATION
  • 2019-03-04 The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantation in BONE MARROW TRANSPLANTATION
  • 2019-01-24 The new refined minnesota risk score for acute graft-versus-host disease predicts overall survival and non-relapse mortality after T cell-replete haploidentical stem cell transplant with post-transplant cyclophosphamide in BONE MARROW TRANSPLANTATION
  • 2018-11-06 Post-transplantation cyclophosphamide-based haploidentical versus Atg-based unrelated donor allogeneic stem cell transplantation for patients younger than 60 years with hematological malignancies: a single-center experience of 209 patients in BONE MARROW TRANSPLANTATION
  • 2018-09-19 Correction: The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation in BONE MARROW TRANSPLANTATION
  • 2018-04-27 CD3+ graft cell count influence on chronic GVHD in haploidentical allogeneic transplantation using post-transplant cyclophosphamide in BONE MARROW TRANSPLANTATION
  • 2018-03-09 Cost-effectiveness analysis of haploidentical vs matched unrelated allogeneic hematopoietic stem cells transplantation in patients older than 55 years in BONE MARROW TRANSPLANTATION
  • 2018-02-07 Correction: Corrigendum: Disease status is a more reliable predictive factor than histology in lymphoma patients after reduced-intensity conditioning regimen and allo-SCT in BONE MARROW TRANSPLANTATION
  • 2018-01-15 The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation in BONE MARROW TRANSPLANTATION
  • 2018-01-12 Comparable survival using a CMV-matched or a mismatched donor for CMV+ patients undergoing T-replete haplo-HSCT with PT-Cy for acute leukemia: a study of behalf of the infectious diseases and acute leukemia working parties of the EBMT in BONE MARROW TRANSPLANTATION
  • 2017-12-21 Tandem autologous-haploidentical transplantation is a feasible and effective program for refractory Hodgkin lymphoma in BONE MARROW TRANSPLANTATION
  • 2017-12-18 Outcomes of haploidentical stem cell transplantation for chronic lymphocytic leukemia: a retrospective study on behalf of the chronic malignancies working party of the EBMT in BONE MARROW TRANSPLANTATION
  • 2017-05-03 Erratum: Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphoma in BONE MARROW TRANSPLANTATION
  • 2017-01-16 Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphoma in BONE MARROW TRANSPLANTATION
  • 2017-01-09 Factors predicting outcome after allogeneic transplant in refractory acute myeloid leukemia: a retrospective analysis of Gruppo Italiano Trapianto di Midollo Osseo (GITMO) in BONE MARROW TRANSPLANTATION
  • 2017-01-09 Reduced-intensity and non-myeloablative allogeneic stem cell transplantation from alternative HLA-mismatched donors for Hodgkin lymphoma: a study by the French Society of Bone Marrow Transplantation and Cellular Therapy in BONE MARROW TRANSPLANTATION
  • 2016-12-12 Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation for high-risk AML in BONE MARROW TRANSPLANTATION
  • 2016-10-21 Dual PI3K/ERK inhibition induces necroptotic cell death of Hodgkin Lymphoma cells through IER3 downregulation in SCIENTIFIC REPORTS
  • 2016-10-17 Outcomes of Hodgkin lymphoma patients who relapse after allogeneic stem cell transplantation in BONE MARROW TRANSPLANTATION
  • 2016-09-20 Re-discovering NK cell allo-reactivity in the therapy of solid tumors in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2016-08-15 Comparable outcomes with marrow or peripheral blood as stem cell sources for hematopoietic cell transplantation from haploidentical donors after non-ablative conditioning: a matched-pair analysis in BONE MARROW TRANSPLANTATION
  • 2016-08-08 The novel PI3K-δ inhibitor TGR-1202 enhances Brentuximab Vedotin-induced Hodgkin lymphoma cell death via mitotic arrest in LEUKEMIA
  • 2016-07-18 The calcineurin inhibitor and the intensity of the conditioning regimen may affect the occurrence of polyomavirus-associated hemorrhagic cystitis after haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide in BONE MARROW TRANSPLANTATION
  • 2016-05-05 Post-transplant cyclophosphamide-based haplo-identical transplantation as alternative to matched sibling or unrelated donor transplantation for non-Hodgkin lymphoma: a registry study by the European society for blood and marrow transplantation in LEUKEMIA
  • 2016-04-04 Italian consensus conference for the outpatient autologous stem cell transplantation management in multiple myeloma in BONE MARROW TRANSPLANTATION
  • 2016-03-21 The patient’s CMV serological status affects clinical outcome after T-cell replete haplo-HSCT and post-transplant cyclophosphamide in BONE MARROW TRANSPLANTATION
  • 2016-03-02 Erratum: Tacrolimus compared with cyclosporine A after haploidentical T-cell replete transplantation with post-infusion cyclophosphamide in BONE MARROW TRANSPLANTATION
  • 2015-11-23 Tacrolimus compared with cyclosporine A after haploidentical T-cell replete transplantation with post-infusion cyclophosphamide in BONE MARROW TRANSPLANTATION
  • 2015-11-09 T-replete haploidentical allogeneic transplantation using post-transplantation cyclophosphamide in advanced AML and myelodysplastic syndromes in BONE MARROW TRANSPLANTATION
  • 2015-06-03 Erratum: Familial haploidentical challenging unrelated donor Allo-SCT in advanced non-Hodgkin lymphomas when matched related donor is not available in BONE MARROW TRANSPLANTATION
  • 2015-04-12 In-vivo dosimetry with Gafchromic films for multi-isocentric VMAT irradiation of total marrow lymph-nodes: a feasibility study in RADIATION ONCOLOGY
  • 2015-03-02 Familial haploidentical challenging unrelated donor Allo-SCT in advanced non-Hodgkin lymphomas when matched related donor is not available in BONE MARROW TRANSPLANTATION
  • 2015-01-26 High-dose melphalan with autologous stem cell support in refractory Hodgkin lymphoma patients as a bridge to second transplant in BONE MARROW TRANSPLANTATION
  • 2014-12-03 Erratum: Nonmyeloablative conditioning, unmanipulated haploidentical SCT and post-infusion CY for advanced lymphomas in BONE MARROW TRANSPLANTATION
  • 2014-11-24 B-cell reconstitution recapitulates B-cell lymphopoiesis following haploidentical BM transplantation and post-transplant CY in BONE MARROW TRANSPLANTATION
  • 2014-09-19 Allogeneic and autologous stem cell transplantation for hepatosplenic T-cell lymphoma: a retrospective study of the EBMT Lymphoma Working Party in LEUKEMIA
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "http://www.grid.ac/institutes/grid.417728.f", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.492743.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.418321.d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.418443.e", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.417011.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.22903.3a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.4708.b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.463833.9", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.14925.3b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.452490.e", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.414603.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.261331.4", 
            "type": "Organization"
          }
        ], 
        "familyName": "Castagna", 
        "givenName": "Luca", 
        "id": "sg:person.0617444457.05", 
        "identifier": [
          {
            "name": "orcid_id", 
            "type": "PropertyValue", 
            "value": "0000-0002-6239-7387"
          }
        ], 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0617444457.05", 
          "https://orcid.org/0000-0002-6239-7387"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2022-10-01T07:18", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/person/person_976.jsonl", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.0617444457.05'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.0617444457.05'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.0617444457.05'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.0617444457.05'


     

    This table displays all metadata directly associated to this object as RDF triples.

    43 TRIPLES      11 PREDICATES      24 URIs      8 LITERALS      3 BLANK NODES

    Subject Predicate Object
    1 sg:person.0617444457.05 schema:affiliation N9f74ef08d9964e02a677aea25fae2f3f
    2 grid-institutes:grid.14925.3b
    3 grid-institutes:grid.22903.3a
    4 grid-institutes:grid.261331.4
    5 grid-institutes:grid.414603.4
    6 grid-institutes:grid.417011.2
    7 grid-institutes:grid.418321.d
    8 grid-institutes:grid.418443.e
    9 grid-institutes:grid.452490.e
    10 grid-institutes:grid.463833.9
    11 grid-institutes:grid.4708.b
    12 grid-institutes:grid.492743.f
    13 schema:familyName Castagna
    14 schema:givenName Luca
    15 schema:identifier N379ebfd75be241c3bb0fc9799b2e6aa1
    16 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0617444457.05
    17 https://orcid.org/0000-0002-6239-7387
    18 schema:sdDatePublished 2022-10-01T07:18
    19 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    20 schema:sdPublisher Nb9ed320c1bc14ed5ae5660e8acdf5b60
    21 sgo:license sg:explorer/license/
    22 sgo:sdDataset persons
    23 rdf:type schema:Person
    24 N379ebfd75be241c3bb0fc9799b2e6aa1 schema:name orcid_id
    25 schema:value 0000-0002-6239-7387
    26 rdf:type schema:PropertyValue
    27 N9f74ef08d9964e02a677aea25fae2f3f schema:affiliation grid-institutes:grid.417728.f
    28 sgo:isCurrent true
    29 rdf:type schema:OrganizationRole
    30 Nb9ed320c1bc14ed5ae5660e8acdf5b60 schema:name Springer Nature - SN SciGraph project
    31 rdf:type schema:Organization
    32 grid-institutes:grid.14925.3b schema:Organization
    33 grid-institutes:grid.22903.3a schema:Organization
    34 grid-institutes:grid.261331.4 schema:Organization
    35 grid-institutes:grid.414603.4 schema:Organization
    36 grid-institutes:grid.417011.2 schema:Organization
    37 grid-institutes:grid.417728.f schema:Organization
    38 grid-institutes:grid.418321.d schema:Organization
    39 grid-institutes:grid.418443.e schema:Organization
    40 grid-institutes:grid.452490.e schema:Organization
    41 grid-institutes:grid.463833.9 schema:Organization
    42 grid-institutes:grid.4708.b schema:Organization
    43 grid-institutes:grid.492743.f schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...